Clinical trial
Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive…
NCT00393705 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00393705 |
|---|---|
| Title | Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) |
| Official title | A Comparison of Insulin Lispro MM Intensive Mixture Therapy With Progressive Dose-Titration of Insulin Lispro LM or Biphasic Insulin Aspart 30/70 |
| Acronym | S019 |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Insulin Biphasic Aspart 30/70, insulin lispro LM, insulin lispro MM |
| Enrollment | 302 |
| Start date | Oct 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Oct 30, 2006 |
| Last update posted | Jul 20, 2010 |
| Countries | Croatia, Poland, Romania, South Africa, Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: